Bank of America’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-143
Closed -$1K 7690
2016
Q2
$1K Hold
143
﹤0.01% 7067
2016
Q1
$0 Hold
143
﹤0.01% 7700
2015
Q4
$0 Hold
143
﹤0.01% 7655
2015
Q3
$1K Hold
143
﹤0.01% 7128
2015
Q2
$1K Hold
143
﹤0.01% 7196
2015
Q1
$1K Hold
143
﹤0.01% 6952
2014
Q4
$1K Hold
143
﹤0.01% 7608
2014
Q3
$2K Hold
143
﹤0.01% 7838
2014
Q2
$1K Hold
143
﹤0.01% 7961
2014
Q1
$2K Hold
143
﹤0.01% 7573
2013
Q4
$2K Hold
143
﹤0.01% 7678
2013
Q3
$1K Hold
143
﹤0.01% 7797
2013
Q2
$1K Buy
+143
New +$795 ﹤0.01% 7629

Other funds holding BSPM

Bank of America's BSPM Position: Q3 2016 in Review

Bank of America sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q3 2016, closing a stake of 143 shares — an estimated $1K sold.

Bank of America first reported a position in BSPM in Q2 2013 and held it in 13 quarters. The position peaked at $2K in Q3 2014. 8 funds tracked by Wall St. Rank hold BSPM as of Q3 2016.

  • Bank of America reported no remaining Biostar Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Bank of America sold 143 Biostar Pharmaceuticals, Inc. shares in Q3 2016, an estimated $1K.
  • Bank of America first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
  • Bank of America's Biostar Pharmaceuticals, Inc. position peaked at $2K in Q3 2014.
  • 8 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2016.

Based on Bank of America's 13F filing for Q3 2016, filed 14 Nov 2016.